•
Vantive, a planned spin-off from U.S.-based Baxter International (NYSE: BAX) specializing in kidney care, has entered into separate collaboration agreements with the Chinese unit of UK’s Kertone Ltd. and Hangzhou Qiantang Longyue Biotechnology Co., Ltd. at the 7th China International Import Expo (CIIE). These partnerships focus on hemodialysis and peritoneal…
•
Baxter (NYSE: BAX), a leading provider of healthcare products, has announced the appointment of Wu Xin as its China General Manager, effective from October 7, as reported by MedTalent. This strategic move comes amidst the company’s spin-off of its global kidney care business and acute treatment business, which will operate…